loading...

Augmentation Severity Rating Scale (ASRS)

The European Restless Legs Syndrome Study Group (EURLSSG)

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2007

Authors

The European Restless Legs Syndrome Study Group (EURLSSG)

Copyright
ASRS © European Restless Legs Syndrome Study Group - EURLSSG e.V. 2010
Objective
To assess severity of augmentation, the main complication during long-term dopaminergic treatment of restless legs syndrome (RLS)
Therapeutic area
  • Nervous System Diseases
  • Mental Disorders
Therapeutic indication

Restless Legs Syndrome

Type of Clinical Outcome Assessment (COA)
  • pro PRO
COA type depending on the questionnaire's version
Original language(s)
  • English for the UK
Bibliographic reference(s) of the original questionnaire

García-Borreguero D, et al. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome. Sleep Med. 2007 Aug;8(5):455-63 (PubMed abstract)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

The European Restless Legs Syndrome Study Group (EURLSSG)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. 
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Author Website(s)

Additional information on the EURLSSG website

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

ASRS

Czech for Czech Republic
Dutch for the Netherlands*
Finnish for Finland
German for Austria*
German for Germany
Italian for Italy*
Polish for Poland
Spanish for Spain
Swedish for Finland*
Swedish for Sweden
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us